We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Seek Changes for FDA’s Enteral Tube Drug Delivery Guidance
Drugmakers Seek Changes for FDA’s Enteral Tube Drug Delivery Guidance
Several drugmakers have offered suggestions in written comments to the agency for revisions to the FDA’s draft guidance on in vitro testing and labeling of oral drugs intended to be given by enteral tube.